ba0005p104 | Cancer and bone: basic, translational and clinical | ECTS2016
Hong A Ram
, Kim Jung Hee
, Lee Kyung-Hun
, Kim Tae Yong
, Im Seock-Ah
, Kim Tae-You
, Moon Hyung-Gon
, Han Wonshik
, Noh Dong-Young
, Kim Sang Wan
, Shin Chan Soo
Background: Aromatase inhibitors (AIs) increase the risk of fracture in patients with breast cancer. Therefore, we aimed to evaluate the long-term effects of AIs on bone health in postmenopausal women with primary breast cancer.Patients and methods: We performed a retrospective longitudinal observational study in patients with breast cancer who were treated by AIs for ≧3 years (baseline T-score >2.5). Patients with previous anti-osteoporosis...